| Literature DB >> 27073657 |
Azusa Tanimoto1, Shinji Takeuchi1, Hiroshi Yaegashi2, Hiroshi Kotani1, Hidenori Kitai1, Shigeki Nanjo1, Hiromichi Ebi1, Kaname Yamashita1, Hisatsugu Mouri1, Koushiro Ohtsubo1, Hiroko Ikeda3, Seiji Yano1.
Abstract
A 76-year-old female in whom a renal cell carcinoma (RCC) lesion was resected 19 years previously presented to our hospital with cognitive dysfunction. Magnetic resonance imaging and computed tomography revealed nodules in the brain, lung, adrenal gland and a pelvic osteolytic lesion. To identify the primary cancer site, the present study performed endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) of the left adrenal lesion. Consequently, the pathological findings of the tissue obtained by EUS-FNA were similar to those of the previous nephrectomy specimen, revealing that the adrenal lesion was the recurrence of RCC. The majority of the metastatic lesions in the patient were reduced in size by the multiple kinase inhibitor, pazopanib. Contralateral adrenal metastasis of RCC is rare and the use of EUS-FNA in the diagnosis of adrenal lesions remains to be elucidated. This is a rare case of adrenal lesion, diagnosed by EUS-FNA. Therefore, EUS-FNA is considered to be a useful diagnostic modality of adrenal metastases from unidentified primary tumor types.Entities:
Keywords: contralateral adrenal metastasis; endoscopic ultrasound-guided fine-needle aspiration; late recurrence; pazopanib; renal cell carcinoma
Year: 2016 PMID: 27073657 PMCID: PMC4812346 DOI: 10.3892/mco.2016.739
Source DB: PubMed Journal: Mol Clin Oncol ISSN: 2049-9450